MarketCap
Verrica Pharmaceuticals VRCA
€ 3.05
-14.14%
Facebook
X
Telegram
Verrica Pharmaceuticals EV | VRCA
EV Jährlich Verrica Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58.9 M | 50.1 M | 238 M | 223 M | 258 M | 324 M | 357 M | 168 M | -8.05 M | 3.21 M | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 357 M | -8.05 M | 167 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Translate Bio, Inc.
TBIO
|
1.43 B | - | - | $ 2.81 B |  USA |
 |
Trillium Therapeutics Inc.
TRIL
|
83.6 M | - | - | $ 1.94 B |  Canada |
 |
Urovant Sciences Ltd.
UROV
|
37.4 B | - | - | $ 532 M |  Britain |
 |
Acceleron Pharma Inc.
XLRN
|
-182 M | - | - | $ 10.9 B | USA |
 |
Zealand Pharma A/S
ZEAL
|
866 M | - | 0.52 % | $ 821 M |  Danmark |
 |
Zogenix, Inc.
ZGNX
|
18.2 B | - | -4.97 % | $ 664 M | USA |
 |
Yunhong International
ZGYH
|
18.2 B | - | 0.10 % | $ 92.2 M |  China |
 |
ZIOPHARM Oncology, Inc.
ZIOP
|
96.3 B | - | -7.58 % | $ 264 M | USA |
 |
Leap Therapeutics
LPTX
|
-4.36 M | - | 368.57 % | $ 41.9 M | USA |
 |
Cortexyme
CRTX
|
123 M | - | -1.05 % | $ 67.1 M | USA |
 |
Aptorum Group Limited
APM
|
8.14 M | - | - | $ 5.72 M | China |
 |
FSD Pharma
HUGE
|
4.15 M | - | 5743.5 % | $ 69.7 M | Canada |
 |
BioAtla
BCAB
|
52.3 M | $ 1.74 | 0.64 % | $ 102 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
2.48 B | - | - | $ 3.85 B | USA |
 |
ARCA biopharma
ABIO
|
-30.2 M | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
-14.2 M | - | 4.01 % | $ 150 M | Canada |
 |
ADiTx Therapeutics
ADTX
|
9.4 M | - | - | $ 374 | USA |
 |
Aeterna Zentaris
AEZS
|
10.3 M | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
3.93 M | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
9.53 M | - | 1.93 % | $ 17.4 M | USA |
 |
Aileron Therapeutics
ALRN
|
4.02 M | - | 10.36 % | $ 9.8 M | USA |
 |
AlloVir
ALVR
|
-55.1 M | - | 4.14 % | $ 49.1 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
3.01 B | - | - | $ 5.18 B | USA |
 |
Athira Pharma
ATHA
|
-4.92 M | - | - | $ 269 M | USA |
 |
Avenue Therapeutics
ATXI
|
-1.76 M | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
-244 M | - | 1083.1 % | $ 745 M | USA |
 |
AstraZeneca PLC
AZN
|
59.6 B | - | - | $ 96.9 B | Britain |
 |
Brainstorm Cell Therapeutics
BCLI
|
11 M | - | -2.5 % | $ 5.88 M | USA |
 |
BeiGene, Ltd.
BGNE
|
-720 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bio-Path Holdings
BPTH
|
10.3 M | - | - | $ 100 K | USA |
 |
Cara Therapeutics
CARA
|
-9.61 M | - | -3.03 % | $ 260 M | USA |
 |
ChromaDex Corporation
CDXC
|
-34.9 M | - | -0.88 % | $ 598 M | USA |
 |
Caladrius Biosciences
CLBS
|
-12.8 M | - | -16.75 % | $ 25.8 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
-2.16 M | - | -5.98 % | $ 34.1 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-2.16 M | - | -4.36 % | $ 27 M | USA |
 |
Diffusion Pharmaceuticals
DFFN
|
-3.58 M | - | 11.68 % | $ 8.97 M | USA |
 |
Eloxx Pharmaceuticals
ELOX
|
41.9 M | - | -5.68 % | $ 8.28 M | USA |
 |
Enochian Biosciences
ENOB
|
17.3 M | - | - | $ 40.5 M | USA |
 |
Esperion Therapeutics
ESPR
|
1.16 B | - | - | $ 661 M | USA |
 |
Evofem Biosciences
EVFM
|
89.1 M | - | 7.55 % | $ 38.1 M | USA |
 |
Eyenovia
EYEN
|
4.26 M | - | 49.81 % | $ 13.2 M | USA |
 |
FibroGen
FGEN
|
67.2 M | - | - | $ 889 M | USA |
 |
Homology Medicines
FIXX
|
-28.5 M | - | 0.77 % | $ 53.4 M | USA |
 |
Amicus Therapeutics
FOLD
|
4.89 B | - | - | $ 4.47 B | USA |
|
Frequency Therapeutics
FREQ
|
40.2 M | - | - | $ 528 M | USA |
|
Galecto
GLTO
|
-237 M | - | - | $ 762 M | Danmark |
 |
GlycoMimetics
GLYC
|
-176 M | - | 9357.83 % | $ 1.01 B | USA |
 |
Graybug Vision
GRAY
|
8.71 M | - | -11.23 % | $ 9.65 M | USA |
|
Galera Therapeutics
GRTX
|
-5.73 M | - | -32.59 % | $ 7.61 M | USA |